Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by DF Garofalo
Analysis of Eribulin Mesylate Dosing Modifications Impact on Administration Persistence in Patients With Metastatic Breast Cancer (Mbc)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Eribulin Mesylate in the Treatment of Metastatic Breast Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Oral Paclitaxel in the Treatment of Metastatic Breast Cancer (MBC) Patients.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
The Impacts of Inclusion in Clinical Trials on Outcomes Among Patients With Metastatic Breast Cancer (MBC)
PLoS ONE
Multidisciplinary
Eribulin in Pretreated Metastatic Breast Cancer Patients: Results of the TROTTER Trial—a Multicenter Retrospective Study of Eribulin in Real Life
SpringerPlus
Multidisciplinary
Use of Eribulin as an Earlier-Line Chemotherapy for Patients With HER2-negative Metastatic Breast Cancer
Journal of Cancer
Oncology
Outcome of Eribulin as a Late Treatment Line for Thai Metastatic Breast Cancer Patients
OncoTargets and Therapy
Oncology
Pharmacology
Impact of Systemic Therapy on Circulating Leukocyte Populations in Patients With Metastatic Breast Cancer
Scientific Reports
Multidisciplinary
Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate With Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic HER2-Positive Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
